Page 7 - Transcode Therapeutics News Today

Gainers Clearmind Medicine Inc. (NASDAQ:CMND) gained 61.5% to $0.88 in pre-market trading after dropping around 3% on Tuesday. Clearmind engaged...

BOSTON, April 06, 2023 -- TransCode Therapeutics, Inc. , the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today announced that it will... | April 6, 2023

BOSTON, April 05, 2023 -- TransCode Therapeutics, Inc. , the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today announced that it has been... | April 5, 2023

BOSTON, March 31, 2023 -- TransCode Therapeutics, Inc. , the RNA oncology company committed to defeating cancer using RNA therapeutics, today reported financial results for 2022 and recent business... | March 31, 2023

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT ... | March 31, 2023

TransCode Therapeutics, Inc. (NASDAQ:RNAZ – Get Rating) was the target of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 263,500 shares, a decrease of 51.3% from the February 28th total of 541,400 shares. Currently, 2.3% of the company’s stock are short sold. Based on an average […]

BOSTON, Feb. 17, 2023 -- TransCode Therapeutics, Inc. , an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced the closing of its previously... | February 17, 2023

Snap (SNAP) stock is on the move Wednesday as investors react to the company's earnings report for the fourth quarter of 2022.

/PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on "Global Radiotheranostics Market By radioisotope...

Gainers Ambrx Biopharma Inc. (NYSE:AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Brea...